SemaThera, a Montreal-based biotechnology startup, announced it has raised $2.6 million to prepare the company’s lead drug, ST-102, for cl..
It’s a good day for Quebec’s biotech industry.
Today AmorChem launched a seed-stage biotechnology investment fund, AmorChem II, at an i..
AmorChem has invested in and spun out two new startups devoted to tackling inflammation and ocular diseases.
The VC firm separately fun..